Select Medical's Concentra Launches IPO for 22.5M Shares on NYSE
Select Medical's Concentra Launches IPO for 22.5M Shares on NYSE
Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced that Concentra Group Holdings Parent, Inc. ("Concentra"), a wholly owned subsidiary of Select Medical, has launched a roadshow for the initial public offering ("IPO") of 22,500,000 shares of its common stock. Concentra expects to grant the underwriters a 30-day option to purchase up to an additional 3,375,000 shares of its common stock to cover over-allotments, if any. The IPO price is currently expected to be between $23.00 and $26.00 per share. Concentra has been approved to list its common stock on the New York Stock Exchange under the symbol "CON." The IPO is subject to market and other conditions, and there can be no assurance as to whether or when the IPO may be completed, or as to the actual size or terms of the IPO.
Select Medical Holdings Corporation（“Select Medical”）（纽交所：SEM）今天宣布，全资子公司Concentra Group Holdings Parent，Inc.（“Concentra”）为其普通股初始公开发行（“IPO”）推出了一项路演活动，发行2250万股。如果有任何超额配售，Concentra期望授权承销商在期权期内购买多达337.5万股普通股。IPO股价目前预计在23.00美元至26.00美元之间。Concentra已获批将其普通股在纽约证券交易所上市，股票代码为“CON”。IPO取决于市场和其他情况，不能保证IPO是否会完成或何时完成，以及IPO的实际规模或条件。
After the completion of the IPO, Select Medical will own 104,093,503 shares of Concentra's common stock, representing 82.23% of the total outstanding shares of Concentra's common stock (or 80.09% if the underwriters exercise in full their over-allotment option).
IPO完成后，Select Medical将拥有Concentra普通股的104,093,503股，占Concentra普通股总流通股的82.23％（如果承销商全部行使超额配售选择权，则为80.09％）。